Skip to content

Comparison of Postoperative Pain Score Between Perioperative Intravenous Ketamine and Placebo in Patients Undergoing Unilateral Total Knee Arthroplasty Under General Anesthesia

Comparison of Postoperative Pain Score Between Perioperative Intravenous Ketamine and Placebo in Patients Undergoing Unilateral Total Knee Arthroplasty Under General Anesthesia, A Prospective Randomized Controlled Trial Study

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06267638
Enrollment
100
Registered
2024-02-20
Start date
2024-01-22
Completion date
2025-12-31
Last updated
2024-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Keywords

ketamine, total knee arthroplasty, general anesthesia, Total Knee Arthropathy

Brief summary

The goal of this clinical trial is to compare postoperative pain score between perioperative intravenous ketamine and placebo in patients undergoing unilateral total knee arthroplasty under general anesthesia. The main question\[s\] it aims to answer are: * Can perioperative intravenous ketamine reduce postoperative pain score during rest and movement at 0, 2, 4, 8, 12, 18, 24 hours better than no administration of Ketamine in patients undergoing Unilateral total knee arthroplasty under general anesthesia? * Can perioperative intravenous ketamine reduce morphine consumption in postoperative 24 hours, length of hospital stay, first time to receive opioid and side effect or complication from ketamine and opioid better than no administration of Ketamine in patients undergoing Unilateral total knee arthroplasty under general anesthesia? Participants will receive intravenous ketamine intraoperative TKA and comparison group will receive placebo that is normal saline. Researchers will compare perioperative intravenous ketamine and placebo to see postoperative pain score, morphine consumption in postoperative 24 hours, length of hospital stay, first time to receive opioid and side effect or complication from ketamine and opioid.

Interventions

Participants will receive intraoperative ketamine during total knee arthroplasty

DRUGPlacebo group

Participants will receive intraoperative normal saline during total knee arthroplasty

Sponsors

Ministry of Health, Thailand
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

1. A patient undergo unilateral total knee arthroplasty under General anesthesia at Chomthong Hospital Chiang Mai During 2024 to December 2025 2. Age is more than 18 years old 3. ASA (American society of anesthesiologist) status are I,I,III 4. A patient can cooperate in research

Exclusion criteria

* Patients allergic to local anesthetic agent * Patient who has contraindication to use ketamine * Patients has coagulopathy. * Injection site is infected. * Patients with chronic pain received painkillers for more than 3 months. * The patient has a history of opioid use. * The patient has a history of alcohol dependence. * Patients allergic to fentanyl or morphine. * Patient who has unstable cardiovascular disease * Patient who has increase intracranial pressure and high ocular pressure * Pregnancy * The patient who has communication problems cannot describe the level of pain * The patient refused to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
Postoperative pain score at rest and movementpost operative time at 0 ,2 ,4 ,8 ,12 ,18 ,24 hourspain score at rest and movement by numeric rating scale 0-10

Secondary

MeasureTime frameDescription
First time to receive intravenous analgesic drugFirst time to receive intravenous analgesic drug ( From finished anesthetic time until First time to receive intravenous analgesic drug(minute)First time to receive intravenous analgesic drug after operation was finished
Morphine consumptionpost operative time at 0 ,2 ,4 ,8 ,12 ,18 ,24 hoursPost operative morphine consumption or morphine equivalent (milligram)
Length of hospital stayTime that patient was admited to hospital until patient was discharge from hospital.Length of hospital stay : When participant admit to discharge
side effect and complication from ketamine and opioidpost operative time within 24 hoursNumber of Participants with side effect form Ketamine and opioid: Hallucination, Nightmare, Arrythmia , Nausea vomiting respiratory distress ,Pruritus within 24 hours after operation. Do you have hallucination or nightmare? : yes no Nausea vomiting : - Severity of nausea 4 scale : 0 = No 1. =minimal nausea and vomiting don't need medication 2. = nausea and vomiting participant was improved when received medication 3= nausea and vomiting participant wasn't improved when received medication Pruritus score 0= no 1= minimal 2= severe and need medication respiratory distress : sedation scale 0 = awake 1. minimal sedation : response to verbal conversation 2. moderated sedation : sleeping but easy to response to verbal conversation 3. deep sedation : difficult to response to

Countries

Thailand

Contacts

Primary ContactKanokwan Uthaiwan
manarw1@hotmail.com66836999444

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026